Bradycardia · patients with myocardial infarction
It is very uncertain whether lidocaine changes bradycardia compared with dimethylammonium (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival at 30 days after myocardial infarction · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (AEs; adverse drug reaction): asystole · patients with acute myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): asystole compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Ventricular fibrillation · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Coma · patients with myocardial infarction
It is very uncertain whether lidocaine changes coma compared with aprindine (very low certainty).
1 finding from 1 review
Seizures · patients with myocardial infarction
It is very uncertain whether lidocaine changes seizures compared with aprindine (very low certainty).
1 finding from 1 review
Specific behaviour ‐ agitation · patients with myocardial infarction
It is very uncertain whether lidocaine changes agitation compared with aprindine (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival at 30 days after myocardial infarction · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ventricular fibrillation · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (any type) and safety of sealant · patients with myocardial infarction
It is very uncertain whether lidocaine changes safety (AEs; adverse drug reaction): any adverse event compared with pirmenol (very low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): sinus bradycardia · patients with acute myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): sinus bradycardia compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): drowsiness/dizziness · patients with acute myocardial infarction
Lidocaine may leads to higher adverse events (AEs; adverse drug reaction): drowsiness/dizziness compared with placebo or no intervention (low certainty).
1 finding from 1 review
All‐cause mortality · patients with myocardial infarction
It is very uncertain whether lidocaine changes all‐cause mortality compared with disopyramide (very low certainty).
1 finding from 1 review
Cardiac mortality · patients with myocardial infarction
It is very uncertain whether lidocaine changes cardiac mortality compared with disopyramide (very low certainty).
1 finding from 1 review